These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36267362)

  • 1. Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study.
    Lertwattanarak R; Kunavisarut T; Sriussadaporn S
    Int J Endocrinol; 2022; 2022():1705740. PubMed ID: 36267362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
    Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
    J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
    Azizi F; Abdi H; Amouzegar A
    BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose methimazole in control of multiple relapses of Graves' hyperthyroidism: a case report.
    Azizi F; Amouzegar A; Abdi H
    J Med Case Rep; 2021 Apr; 15(1):189. PubMed ID: 33888159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
    Reinwein D; Benker G; Lazarus JH; Alexander WD
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
    Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
    Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves' Hyperthyroidism: A Randomized Controlled Study.
    Sriussadaporn S; Pumchumpol W; Lertwattanarak R; Kunavisarut T
    Int J Endocrinol; 2017; 2017():2619695. PubMed ID: 29403532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
    Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine.
    Azizi F; Abdi H; Mehran L; Perros P; Masoumi S; Amouzegar A
    Endocr Pract; 2023 Apr; 29(4):240-246. PubMed ID: 36649782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to Normalization and Sustainable Normal Serum Thyrotropin Concentrations in Patients with Hyperthyroidism: Comparison of Methimazole and Radioactive Iodine Treatments.
    Azizi F; Saadat N; Abdi H; Mehran L; Masoumi S; Takyar MA; Amouzegar A
    Endocr Pract; 2022 Nov; 28(11):1140-1145. PubMed ID: 35948251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
    Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
    Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction for recurrence following antithyroid drug therapy for Graves' hyperthyroidism.
    Weng H; Tian WB; Xiao ZD; Xu L
    Arch Endocrinol Metab; 2023 May; 67(4):e000609. PubMed ID: 37252698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium ipodate and methimazole in the long-term treatment of hyperthyroid Graves' disease.
    Roti E; Gardini E; Minelli R; Bianconi L; Braverman LE
    Metabolism; 1993 Apr; 42(4):403-8. PubMed ID: 8487661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithyroid drug therapy for Graves' hyperthyroidism: is long-term administration of a small maintenance dose necessary?
    Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
    Endocrinol Jpn; 1991 Apr; 38(2):223-7. PubMed ID: 1684322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.